Additionally, we silenced c-Myc expression in RPMI-8226 cells, and the results indicated that compound D347-2761 enhanced myeloma cell killing abilities in WT RPMI-8226 cells (Additional file 3: Figure S2B). This evidence concerns the gene MYC and plasma cell myeloma.